Science Oriented Solutions (SOS) and Clinical Solutions (CS), Publicis Healthcare Communications Group (PHCG) companies, today announced the successful completion of merging their operations.
Atlanta, Georgia -- April 6, 2005 -- Science Oriented Solutions (SOS) and Clinical Solutions (CS), Publicis Healthcare Communications Group (PHCG) companies, today announced the successful completion of merging their operations. President and Chief Operating Officer of SOS Evan Demestihas, M.D., RPh. will oversee the joint operation.
"Merging the two operations follows a natural synergy that will enable them to expand the range of services they provide to their clients," said Dr. Demestihas.
SOS, founded in 1997, is the first and leading contract medical affairs organization providing outsourcing for essential medical affairs activities. SOS is widely recognized as the sector leader in providing contract medical science liaison services. CS, in operation since 1994, is an integrated marketing agency that creates and implements clinical trial marketing communications and strategies that are protocol-specific and optimize patient recruitment and retention. SOS and Clinical Solutions share office space in Kennesaw, Georgia, a suburb of Atlanta.
While each company will maintain its individual pharmaceutical and biotech client base, Dr. Demestihas adds, "The merging of SOS and CS operations allows for a broader spectrum of services as well as an increase in management support, additional creative capabilities, and enhanced call center services."
About Science Oriented Solutions (SOS)
SOS, a full-service commercial-side medical affairs group, was established in 1997 as the pharmaceutical industry's first Contract Medical Organization (CMO). SOS focuses on delivering comprehensive outsourcing of medical affairs activities, including Medical Science Liaison (MSL) and medical communications services to pharmaceutical, biotechnology and medical device companies and integrates its activities with the client's core commercial and marketing objectives.
Clinical Solutions, in operation since 1994, is an integrated marketing company exclusively focused on optimizing patient recruitment and retention for clinical trials in a wide range of therapeutic areas. CS is known for developing and implementing protocol-specific programs for pharmaceutical, biotechnology, and medical device companies that are strategic, creative and results oriented.
About Publicis Healthcare Communications Group (PHCG)
Publicis Healthcare Communications Group (PHCG), a member of Publicis Groupe S.A., is the largest healthcare communications group in the world. Worldwide healthcare services include Advertising, Medical Education, Sales and Marketing, Medical and Scientific Affairs, and Healthcare Consulting. PHCG offers its clients a strategic partnership, a strong focus on ensuring value for their marketing spend, and exceptional performance on their assignments.
Publicis Groupe (Euronext Paris: 13057, NYSE: PUB) is the world's fourth largest communications group, and a world leader in media counsel and buying. Services are provided in 109 countries on six continents.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.